Agilent Technologies Inc (A)vsIllumina Inc (ILMN)
A
Agilent Technologies Inc
$112.98
-1.07%
HEALTHCARE · Cap: $31.96B
ILMN
Illumina Inc
$126.20
+0.17%
HEALTHCARE · Cap: $19.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Agilent Technologies Inc generates 63% more annual revenue ($7.07B vs $4.34B). ILMN leads profitability with a 19.6% profit margin vs 18.3%. A appears more attractively valued with a PEG of 1.19. ILMN earns a higher WallStSmart Score of 64/100 (C+).
A
Buy61
out of 100
Grade: C+
ILMN
Buy64
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-318.5%
Fair Value
$30.80
Current Price
$112.98
$82.18 premium
Margin of Safety
+54.4%
Fair Value
$255.06
Current Price
$126.20
$128.86 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 20 in profit
Strong operational efficiency at 22.9%
Every $100 of equity generates 33 in profit
Earnings expanding 86.4% YoY
Areas to Watch
Grey zone — moderate risk
Weak financial health signals
Earnings declined 3.6%
Expensive relative to growth rate
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 22.9%. PEG of 1.19 suggests the stock is reasonably priced for its growth.
Bull Case : ILMN
The strongest argument for ILMN centers on Return on Equity, EPS Growth. Profitability is solid with margins at 19.6% and operating margin at 19.7%.
Bear Case : A
The primary concerns for A are Altman Z-Score, Piotroski F-Score, EPS Growth.
Bear Case : ILMN
The primary concerns for ILMN are PEG Ratio, Altman Z-Score.
Key Dynamics to Monitor
A profiles as a mature stock while ILMN is a value play — different risk/reward profiles.
ILMN carries more volatility with a beta of 1.50 — expect wider price swings.
A is growing revenue faster at 7.0% — sustainability is the question.
ILMN generates stronger free cash flow (267M), providing more financial flexibility.
Bottom Line
ILMN scores higher overall (64/100 vs 61/100), backed by strong 19.6% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Illumina Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Visit Website →Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?